Professional Documents
Culture Documents
SYSTEM
CARDIOVASCULAR
SYSTEM
CARDIOVASCULAR SYSTEM
ELECTROCARDIOGRAM
Hearth Sound
Conduction System
PARTS OF THE ECG
1. SA Node – 60-100/min @SVC and RA
P wave – atrial depolarization < 0.11 sec
2. AV Node – 40-60/min
QRS – ventricular depolarization <0.12
3. Bundle of His - right and left branch bundle of his
T wave – ventricular repolarization
4. Purkenji Fibers – 15- 40/min
U wave – PF Repolarization ---- abn
CV=SV x HR
SV =60-80ml
DYSTRRYTHMIAS-
1. Sinus Tachycardia
2. Sinus Bradycardia
4. Atrial Fibrillation
Manifestation : Palpitation, dyspnea , pulmonary edema, signs of cerebral and vascular hypoxia
5. V-Fib
Management: defib
Management – Lidocaine
7. Asystole/ cardiac Standstill
CPR, EPI,
8. Torsades de Pointes
DOC- MGSULFATE
Risk factor:
Modifiable: HPN, Hyperlipidemia, DM, Obesity, OCP ( Estrogen), Cigarette Smoking, Sedendary lifestyle,
improper diet
OW- 25-29.9
Obese 30-39.9
Morbid 40-up
Pathophysiology:
Sx: 1 Asyptomatic
2. Chest Pain
Diagnostic:
Trigylceride <200mg/dl
Brachial Artery
Managements
1. Antilipidemic drugs
➢ Statins- simvastatin
- Cholestyramine
- Chlofibrates
4. Niacin/ B3
- Multiple SE
Nursing management
Knowledge Deficit
Low sat , High complex cartbohydrates, , increase K +, smoking cessation, mod Alchoholism
ANGINA PECTORIS
Angina Pectoris
Causes –
CAD (Atherosclerosis )
Anemia
Hyperthyroidism
Chronic Hypertension
2. Pallor
Myocardial schemia
Anaerobic metabolism
Chest pain
Types of Angina
Emotional Stress
Exertion
Expo to cold
2.Unstable -- @ rest
3. Prinzmetal/ Variant
Diagnostic
ST depression
T wave inversion
2.Avoid bronchodilators
Management
NTG- Nitrates
NC
Aspilet – diphendamole
Clopidogrel
Ticlopidine
2. SE=-GI upset
CCB-Veraparil, Diltiazem
Nursing management
Assess Vs, Positioning Semi Fowler 30-45 degress to decrease vascular resistant
1. Closed
MYOCARDIAL INFARCTION
Thromboembolism
Atrial Fibrillation
Hemorrhage
M.I.
hypo-tachy-tachy)
PNS (rest)
SNS (fight/flight)
2. heart failure
3.Dreller ’s Syndrome
f r i c t i o n r u b , a n d f e v e r.
Pathophysiology
Myocardial necrosis
Increase SNS
Ventricular constriction
Bradycardia
Sx.
P- rovoke
S-everity
2. Increase PR, RR
3. DOB
5. Palor – cyanosis
Diagnostic
1. ECG
ST elevation
Prolonged Q wave
T inversion
Troponin I –confirm
Myoglobin – 1st
CKMB
AST
Management
NURSING CONSIDERATIONS
NURSING CONSIDERATIONS
Enoxaparin – LMW- SQ
NURSING CONSIDERATIONS
4. Antiplatelet
5. Anti dysrhythmia
Nursing Management
1. Acute Pain
1. Shock
2.Heart failure
4. Cardiac tamponade
Management : Pericardiocentesis
➢ Sinus Bradycardia
SA > 100, ECG – regular , management : BB, CCB, Digoxin
➢ Sinus Bradycardia
SA < 60, Management : Atropine Sulfate
nx consideration: do not
Management: Pacemaker
Generator; Battery 5-10 years go to places w high
Management : Lidocaine
➢ Ventricular Tachycardia
➢ > 150-250bpm
No P wave
1 form QRS
➢ Ventricular Fibrilation
ECG- disorganized and chaotic
Mangement : Defib, CPR, Epi
CARDIOVERSION DEFIBRILATION
Synchronized QRS (R wave ) Asynchronized
Sedated Unconscious
500-1000 J 200-360J
AFIB, V.Tach. SVT V.Fib, P VTach, Asystole
nu ubraem)
- Inability of the heart to get adequate CO to meet the body’s metabolic demand
Chronic Hypertension
Pulmonary Embolism
M.I
RHD
Pathophysiology
RSHF LSHF
INCREASE VENOUS CONGESTION PULMONARY CONGESTION- LUNG EDEMA
Sx:
➢ HPN
➢ Increase PR- palpitation
➢ Cyanosis
➢ Oligoria
➢ Restlessness
➢ Edema – late sign due to increase hydrostatic pressure
Diagnostic :
4. Hemodynamic Monitoring
6. ABG
Management :
MOA: increase Ca ++ influx across myocardial cells --- (+) innotripc effect , (-) chronotropic effect
➢ Monitoring of ECG
hypoK hyperK
N. Management
Classification
Classification SP DP
Pre HPN 120-139 80-89
Stage 1 140-149 90-99
Stage 2 160-179 100-109
HPN Crisis 180-110 180-120
Sx:
1. Asymptomatic
2. Nuchal Headache
3. Blurring of vision
4. N/V
5. Dizziness
6. Epistaxis
Diagnostics
Bp Monitoring
ECG
CXR
Urine Analysis to detect the cause
Management
A. ACE INHIBITORS
MOA - inhibits conversion of A1 to A2
Example. Captopril
C. BETA BLOCKERS
- Blocks A1, A2, B1,B2
Examples :
Metoprolol (Selective or Cardioselective beta blockers)
Carvedilol selectively antagonizes alpha-1 adrenergic receptors; antagonizes beta-1 and beta-2
adrenergic receptors nonselectively. That is, Carvedilol is a selective alpha and non-selective beta
blocker.
Labetalol selectively antagonizes alpha-1 adrenergic receptors; antagonizes beta-1 and beta-2
adrenergic receptors nonselectively. That is, labetalol is a selective alpha and non-selective beta blocker.
D. CALCIUM CHANNEL BLOCKER
E. DIURETICS
Thiazide -decrease sodium reabsorption and therefore decreased fluid reabsorption
Example: Hydrochlorothiazide
F. SYMPATHOLYTICS
- inhibits SNS
Example- Clonidine , Methyldopa
G. Vasodilators
Example- Hydralazine
ANEURISM
➢ Permanent dilatation of a part of the artery
Chronic hypertension
Congenital malformation
Types:
2. FUSIFORM-both side
Diagnostics
CT scan
UTZ
CXR
Management
I. Anti HPN
II. Antilipidemics
Surgery – Endovascular stent
Surgical resection with anastomosis
Nursing Management
I. Ineffective Tissue Perfusion- peripheral
➢ Supine, flat on bed
➢ Assess VS
➢ Avoid abdominal palpation
➢ Avoid Valsalva maneuver – lactoluse , enema
Blood clots
Occlusion
Skin color changes / decrease peripheral 02
Sx
Dx. PE + HX
Angiography
Nursing management
1. NSAIDS
2. VD- Nifedipine , hydralzine
3. Amputation – Symes Surgery – ankle
Nursing managements
I . Ineffcetive Tissue Perfusion – peripheral
➢ Assess VS, skin color, temp (cold ) , peripheral pulses
➢ POS – reversed Trendelenburg – extended
➢ Pentoxifylline – to decrease blood viscosity
➢ Foot Care
➢ Stop smoking
➢ Warm temp
➢ Gloves
Deep Vein Thrombosis
RF- Pregnancy
OCP
Smoking
Hip/Abdominal/Pelvic surgery
Immobility
Sx.
➢ Homan’s Sign- cvalf pain upon dorsiflesion
➢ Edema
➢ Erythema/ Redness ®
➢ Warm to touch- C
➢ Pain/ tenderness- d
➢ Swelling- t
➢ Loss of function – FL
Compli- P.E
Management
➢ Thrombolytics
➢ Anticoagulants
Parenteral Oral
Heparin-IV, SQ Warfarin – Comadin
SQ – LMW ( dalteparin, enoxaparin) PO
Check PTT Check PT/INR